Cannabis Sativa Inc (CBDS) and THC Farmaceuticals, Inc (CBDG) announced today that they have entered into an agreement for TRL to develop for CBDS terpene based products from CBDS’ patent pending stain of Cannabis known as “CTA.” As part of the agreement CBDG shall pay CBDS 10,000,000 hempcoins for the non-exclusive right to sell products […]